Tag: IDRx

news-09082024-080227

Advancing GIST Drug: IDRx Secures $120 Million Funding

IDRx, a precision oncology company based in the US, recently announced the successful completion of a $120 million series B preferred stock financing round....
© ManchesterDaily.uk - Stay Connected with Manchester Daily – News That Matters